How to buy Shockwave Medical stock (SWAV)

Shockwave Medical is a medical devices business based in the US. Shockwave Medical shares (SWAV) are listed on the NASDAQ and all prices are listed in US Dollars. Shockwave Medical employs 1,468 staff and has a trailing 12-month revenue of around $788 million.

Our top picks for where to buy Shockwave Medical stock

Buy Shockwave Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Shockwave Medical stock price (NASDAQ: SWAV)

Use our graph to track the performance of SWAV stocks over time.

Shockwave Medical shares at a glance

• Key figures

Information last updated 2024-07-21.

52-week range	$183.76 - $334.90
50-day moving average more info button	$326.86
200-day moving average more info button	$241.38
Wall St. target price	$324.27
PE ratio more info button	78.7647
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$4.25

Is it a good time to buy Shockwave Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Shockwave Medical stock undervalued or overvalued?

Valuing Shockwave Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Shockwave Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Shockwave Medical's P/E ratio

Shockwave Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 79x. In other words, Shockwave Medical shares trade at around 79x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Shockwave Medical's EBITDA

Shockwave Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $180.3 million.

The EBITDA is a measure of a Shockwave Medical's overall financial performance and is widely used to measure a its profitability.

Shockwave Medical financials

Revenue TTM	$788 million
Operating margin TTM	19.38%
Gross profit TTM	$424.7 million
Return on assets TTM	8.68%
Return on equity TTM	24.73%
Profit margin	20.75%
Book value	$20.04
Market Capitalization more info button	$12.6 billion

TTM: trailing 12 months

Shockwave Medical share dividends

We're not expecting Shockwave Medical to pay a dividend over the next 12 months.

Shockwave Medical share price volatility

Over the last 12 months, Shockwave Medical's shares have ranged in value from as little as $183.76 up to $334.9. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Shockwave Medical's is 0.879. This would suggest that Shockwave Medical's shares are less volatile than average (for this exchange).

Shockwave Medical overview

Shockwave Medical, Inc. , a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors.

Frequently asked questions

What percentage of Shockwave Medical is owned by insiders or institutions?
Currently 1.195% of Shockwave Medical shares are held by insiders and 98.726% by institutions. How many people work for Shockwave Medical?
Latest data suggests 1,468 work at Shockwave Medical. When does the fiscal year end for Shockwave Medical?
Shockwave Medical's fiscal year ends in December. Where is Shockwave Medical based?
Shockwave Medical's address is: 5403 Betsy Ross Drive, Santa Clara, CA, United States, 95054 What is Shockwave Medical's ISIN number?
Shockwave Medical's international securities identification number is: US82489T1043 What is Shockwave Medical's CUSIP number?
Shockwave Medical's Committee on Uniform Securities Identification Procedures number is: 82489T104